Cargando…
Fibroblast Growth Factor 21 as a Potential Biomarker for Improved Locomotion and Olfaction Detection Ability after Weight Reduction in Obese Mice
Obesity is one of the most challenging diseases of the 21st century and is accompanied by behavioural disorders. Exercise, dietary adjustments, or time-restricted feeding are the only successful long-term treatments to date. Fibroblast growth factor 21 (FGF21) plays a key role in dietary regulation,...
Autores principales: | Power Guerra, Nicole, Parveen, Alisha, Bühler, Daniel, Brauer, David Leon, Müller, Luisa, Pilz, Kristin, Witt, Martin, Glass, Änne, Bajorat, Rika, Janowitz, Deborah, Wolkenhauer, Olaf, Vollmar, Brigitte, Kuhla, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470262/ https://www.ncbi.nlm.nih.gov/pubmed/34578793 http://dx.doi.org/10.3390/nu13092916 |
Ejemplares similares
-
The effect of different weight loss strategies to treat non-alcoholic fatty liver disease focusing on fibroblast growth factor 21
por: Power Guerra, Nicole, et al.
Publicado: (2022) -
Leptin deficiency-caused behavioral change – A comparative analysis using EthoVision and DeepLabCut
por: Bühler, Daniel, et al.
Publicado: (2023) -
Dietary-Induced Low-Grade Inflammation in the Liver
por: Power Guerra, Nicole, et al.
Publicado: (2020) -
[(18)F]GE-180-PET and Post Mortem Marker Characteristics of Long-Term High-Fat-Diet-Induced Chronic Neuroinflammation in Mice
por: Müller, Luisa, et al.
Publicado: (2023) -
Evaluation of Two Liver Treatment Strategies in a Mouse Model of Niemann–Pick-Disease Type C1
por: Ebner, Lynn, et al.
Publicado: (2018)